ArticleACS medicinal chemistry letters2023

Novel 2,5-Diazabicyclo[4.2.0]octanes as GLP-1 Receptor Modulators for Treating Type 2 Diabetes.

Ram W SabnisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.